摘要
回顾分析2021年1月至2021年6月我院新型冠状病毒疫苗(北京生物生产)接种后发生的19例急性荨麻疹的临床资料。19例患者中,男8例,女11例,最小年龄18岁,最大年龄60岁。1例患者于疫苗注射后1小时,周身出现红色风团,喉头水肿,轻微憋喘症状,其余18例均于注射疫苗24小时内周身出现风团,瘙痒明显,无发热、关节痛等伴随症状,19例患者给予相应治疗后,均痊愈。
The clinical data of 19 cases with acute urticaria after vaccination of COVID-19 vaccine(vero cell),(Beijing Institute of Biological Products Co,Ltd) were retrospectively analyzed in our hospital from January 2021 to June 2021.Of 19 patients,8 were males and 11 were females,aged from 18 to 60 years old.One patient presented with wheals,laryngeal edema,with slight suffocation after 1 h of vaccination,and 18 patients presented with wheals and itching after 24 h of vaccination.All 19 patients were cured after treatment.
作者
万笑
魏志平
路全胜
WAN Xiao;WEI Zhiping;LU Quansheng(Department of Dermatology,The People' Hospital of Jiawang District of Xuzhou,Xuzhou 221000,Jiangsu,China;Department of Dermatology,Affiliated Hospital of Xuzhou Medical University,Xuzhou 221000,China)
出处
《中国麻风皮肤病杂志》
2022年第3期170-171,共2页
China Journal of Leprosy and Skin Diseases
基金
徐州市卫生健康委青年医学科技创新项目(编号:XWKYHT20200011)。
关键词
新型冠状病毒疫苗
急性荨麻疹
临床分析
COVID-19 vaccine(vero cell),Inactivated
acute urticaria
clinical analysis